Document:

Orgenesis Inc.: Exhibit 10.22 - Filed by newsfilecorp.com

SECURITIES PURCHASE AGREEMENT 

This SECURITIES PURCHASE AGREEMENT dated as of October
30, 2015 (this “Agreement”) by and between Orgenesis Inc., a Nevada
corporation (the “Company”), and _________________(the
“Purchaser”). 

WHEREAS, the Company wishes to undertake a financing,
and pursuant to the terms and conditions of this Agreement, from time to time
and as needed by the Company, the Company may issue and sell to the Purchaser
and the Purchaser agrees to acquire from the Company, unsecured notes of the
Company having an aggregate principal amount not exceeding _______Million
Dollars ($____________) in the form of Exhibit A attached hereto
(each, a “Note”, and collectively, the “Notes”). 

NOW, THEREFORE, the parties
hereto hereby agree as follows: 

ARTICLE I 
PURCHASE AND SALE OF SECURITIES;
RESTRICTIVE LEGENDS 

Section 1.1      Purchase and Sale
of Notes. Upon the following terms and conditions, at the Company’s sole
option and discretion, the Company shall issue, sell and deliver to the
Purchaser from time to time as needed, and the Purchaser shall purchase from the
Company, the Notes, up to an aggregate amount of $______________(the
“Purchase Price”). The Company and the Purchaser are executing and
delivering this Agreement in accordance with and in reliance upon the exemption
from securities registration afforded by Section 4(a)(2) of the U.S. Securities
Act of 1933, as amended, and the rules and regulations promulgated thereunder
(the “Securities Act”), including Regulation D (“Regulation D”),
and/or upon such other exemption from the registration requirements of the
Securities Act as may be available with respect to any or all of the investments
to be made hereunder. 

Section 1.2     Issuance of Commitment
Warrants. In consideration of the Purchaser’s commitment to lend to the
Company up to the Purchase Price, upon execution of this Agreement by the
Company and the Purchaser, the Company shall issue to the Purchaser warrants to
purchase up to _________ 1 shares of the Company’s common stock, par
value $0.0001 per share (the “Common Stock”), exercisable from the Termination
Time (as defined in Section 1.3 (c ) below) through the third anniversary of the
Termination Time), at a per share exercise price of $0.53, and otherwise shall
contain the terms and condition specified in, and be in such form, as Exhibit
B attached hereto (the “Commitment Warrants”). The Commitment Warrants are
subject to cancellation if, for any reason whatsoever, the Purchaser does not
honor a request by the Company for an Advance Amount (as defined in Section
1.3(a)) that is duly presented to the Purchaser as provided in Section 1.3(a)
..

Section 1.3     Release of Funds to the
Company. 

(a)     From time to time and as may be
needed by the Company in its sole discretion, upon the Company’s written request
to the Purchaser for an advance, the Purchaser hereby agrees to advance the sum
of $500,000 or, if less, the remaining amount of the Purchase Price (an
“Advance Amount”), and the Purchaser shall be entitled to the
issuance of a Note in the principal amount of $500,000 or such lesser amount. As
soon as reasonably practicable after the Company provides such written request
for an advance to the Purchaser, but in any event within five (5) business days
thereafter, the Purchaser shall cooperate with the Company to transfer an
Advance Amount to an account identified by the Company in such written request,
and the Company shall issue and deliver to the Purchaser a Note. The aggregate
principal amount of the Notes issued hereunder shall not exceed the Purchase
Price.

(b)     Issuance of Drawdown
Warrants. Upon the issuance of each Note, the Company shall also issue to
the Purchaser a warrant to purchase up to _____________shares of the Company
Common Stock (the “Drawdown Warrant”; together with the Commitment Warrant, the
“Warrants”). Each Drawdown warrant shall be exercisable through the third
anniversary of its issuance and for a total of _________ 2 shares of Common Stock at a per
share exercise price of $0.53, and shall contain the terms and condition
specified in, and be in such form, as Exhibit B attached hereto
(each a “Warrant” and collectively, the “Warrants”; together with
the Notes, the “Securities”).

______________________________________
1Insert
number of shares that is equal to the quotient of: (.25 X Purchase Price) /
$0.53 . 

1 

(c)     Notwithstanding anything to the
contrary contained herein, if the entire Purchase Price has not been funded by
5:00 p.m. Eastern Time on the Termination Time (as defined below), and the
Purchaser and Company have not mutually agreed to extend such Termination Time
to a later time, the Purchaser shall not be obligated to fund any additional
portions of the Purchase Price to the Company. As used herein, the “Termination
Time” shall mean November 30, 2016 or, if earlier, upon the closing of an Equity
Based Financing in an amount exceeding $10 million; provided that in the
event of such investment the Purchaser shall be entitled to early repayment only
to the extent to which the gross proceeds of such investment exceed $10 million;
provided further that any such repayment shall be allocated pro rata
among all Notes then outstanding. The term “Equity Based Financing” shall mean
the private placement by the Company of shares of Common Stock, or securities
convertible into Common Stock, with aggregate gross proceeds to the Company of
at least $10,000,000.

(d)     Acceptance by the Company.
This Agreement will not be binding on the Company until accepted by it as
evidenced by the Company’s execution of the Agreement in the space provided on
the signature page hereof and, notwithstanding the date first written above, the
Agreement will be deemed entered into on the date of such execution by the
Company. 

(e)     Legend on the
Notes/Warrants. Each Note and Warrant shall be stamped or otherwise
imprinted with a legend substantially in the following form (in addition to any
legend required by applicable state securities or “blue sky” laws): 

THE SECURITES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR ANY STATE
SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS
REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES LAWS
OR AMBIENT CORPORATION SHALL HAVE RECEIVED AN OPINION OF COUNSEL THAT
REGISTRATION OF SUCH SECURITIES UNDER THE SECURITIES ACT AND UNDER THE
PROVISIONS OF APPLICABLE STATE SECURITIES LAWS IS NOT REQUIRED. 

ARTICLE II 
REPRESENTATIONS AND WARRANTIES 

Section 2.1     Representations and
Warranties of the Company. The Company hereby represents and warrants to the
Purchaser, as of the date hereof and as of each date a Note and Warrant is
issued to the Purchaser hereunder (each a “Closing Date”), as follows:

(a)     Organization, Good Standing and
Power. The Company is a corporation duly incorporated, validly existing and
in good standing under the laws of the State of Nevada and has the requisite
corporate power to own, lease and operate its properties and assets and to
conduct its business as it is now being conducted. The Company is duly qualified
as a foreign corporation to do business and is in good standing in every
jurisdiction in which the nature of the business conducted or property owned by
it makes such qualification necessary except for any jurisdiction(s) (alone or
in the aggregate) in which the failure to be so qualified will not have a
material adverse effect on the business, operations, properties, or financial
condition of the Company or its Subsidiaries. No proceeding or action has been
instituted in any such jurisdiction revoking, limiting or curtailing or seeking
to revoke, limit or curtail such power and authority or qualification. 

(b)     Authorization; Enforcement.
The Company has the requisite corporate power and authority to enter into and
perform its obligations under this Agreement, the Notes, the Warrants, and each
of the other agreements or instruments entered into, or delivered, by the
parties hereto in connection with the transactions contemplated by this
Agreement (collectively, the “Transaction Documents”) and to issue and sell the Securities in
accordance with the terms hereof. The execution, delivery and performance of the
Transaction Documents by the Company and the consummation by it of the
transactions contemplated thereby, including, without limitation, the issuance
of the Securities, have been duly and validly authorized by all necessary
corporate action, and no further consent or authorization of the Company, its
board of directors or stockholders is required. When executed and delivered by
the Company, each of the Transaction Documents shall constitute a valid and
binding obligation of the Company enforceable against the Company in accordance
with its terms, except as such enforceability may be limited by applicable
bankruptcy, reorganization, moratorium, liquidation, conservatorship,
receivership or similar laws relating to, or affecting generally the enforcement
of, creditor’s rights and remedies or by other equitable principles of general
application. 

_________________________________
2Insert number
of shares that is equal to the quotient of: (.50 X Advance Amount) / $0.53 .

2 

(c)     Issuance of Notes/Warrants.
The Notes and Warrants to be issued at each Closing have been duly authorized by
all necessary corporate action. When paid for or issued in accordance with the
terms hereof, each of the Notes and Warrants shall be validly issued and
outstanding, free and clear of all liens, encumbrances and rights of refusal of
any kind.

(d)     Commission Documents,
Financial Statements. The Common Stock of the Company is registered pursuant
to Section 12(g) of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), and the Company, for the two years preceding the date
hereof, has filed all reports, schedules, forms, statements and other documents
required to be filed by it with the Commission pursuant to the reporting
requirements of the Exchange Act. At the times of their respective filings, all
of the aforementioned reports, schedules, forms, statements and other documents
required to be filed by it with the Commission (the “Commission
Documents”) complied in all material respects with the requirements of the
Securities Act and the Exchange Act and the rules and regulations of the
Commission promulgated thereunder, and did not contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein or
necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading. As of their respective dates, the
financial statements of the Company included in the Commission Documents
complied as to form in all material respects with applicable accounting
requirements and the published rules and regulations of the Commission. Such
financial statements have been prepared in accordance with generally accepted
accounting principles applied on a consistent basis during the periods involved
(except (i) as may be otherwise indicated in such financial statements or the
notes thereto or (ii) in the case of unaudited interim statements, to the extent
they may not include footnotes or year-end adjustments or may be condensed or
summary statements), and fairly present in all material respects the financial
position of the Company and its Subsidiaries as of the dates thereof and the
results of operations and cash flows for the periods then ended (subject, in the
case of unaudited statements, to normal year-end audit adjustments). 

(e)     No Undisclosed Liabilities.
The Company has not incurred any liabilities, obligations, claims or losses
(whether liquidated or unliquidated, secured or unsecured, absolute, accrued,
contingent or otherwise) other than those incurred in the ordinary course of the
Company’s business or which, individually or in the aggregate, are not
reasonably likely to have a material adverse effect on the Company’s business
and operations. 

Section 2.2     Representations and
Warranties of the Purchaser. The Purchaser hereby represents and warrants to
the Company as follows as of the date hereof and as of each Closing Date: 

(a)     Organization and Standing of the
Purchaser. [The Purchaser is an entity organized, validly existing
and in good standing under the laws of the jurisdiction of its
organization]. 

(b)     Authorization and Power. The
Purchaser has the requisite power and authority to enter into and perform its
obligations under the Transaction Documents and to purchase the Notes being sold
to it hereunder. The execution, delivery and performance of the Transaction
Documents by the Purchaser and the consummation by it of the transactions
contemplated hereby have been duly authorized by all necessary action, and no
further consent or authorization of the Purchaser is required. When executed and
delivered by the Purchaser, the other Transaction Documents shall constitute
valid and binding obligations of the Purchaser enforceable against the Purchaser
in accordance with their terms, except as such enforceability may be limited by
applicable bankruptcy, insolvency, reorganization, moratorium, liquidation,
conservatorship, receivership or similar laws relating to, or affecting generally the enforcement of, creditor’s rights and
remedies or by other equitable principles of general application. 

3 

(c)     No Conflict. The execution,
delivery and performance of the Transaction Documents by the Purchaser and the
consummation by the Purchaser of the transactions contemplated thereby and
hereby do not and will not (i) violate any provision of the Purchaser’s charter
or organizational documents, (ii) conflict with, or constitute a default (or an
event which with notice or lapse of time or both would become a default) under,
or give to others any rights of termination, amendment, acceleration or
cancellation of, any agreement, mortgage, deed of trust, indenture, note, bond,
license, lease agreement, instrument or obligation to which the Purchaser is a
party or by which the Purchaser’s respective properties or assets are bound, or
(iii) result in a violation of any federal, state, local or foreign statute,
rule, regulation, order, judgment or decree (including federal and state
securities laws and regulations) applicable to the Purchaser or by which any
property or asset of the Purchaser are bound or affected, except, in all cases,
other than violations pursuant to clauses (ii) or (iii) (with respect to federal
and state securities laws) above, except, for such conflicts, defaults,
terminations, amendments, acceleration, cancellations and violations as would
not, individually or in the aggregate, materially and adversely affect the
Purchaser’s ability to perform its obligations under the Transaction Documents.

(d)      Acquisition for
Investment. The Purchaser is purchasing the Securities solely for its own
account and not with a view to, or for sale in connection with, public sale or
distribution thereof. The Purchaser does not have a present intention to sell
the Securities, nor a present arrangement (whether or not legally binding) or
intention to effect any distribution thereof to or through any person or entity.
The Purchaser acknowledges that it (i) has such knowledge and experience in
financial and business matters such that Purchaser is capable of evaluating the
merits and risks of Purchaser’s investment in the Company, (ii) is able to bear
the financial risks associated with an investment in the Securities and (iii)
has been given full access to such records of the Company and to the officers of
the Company as it has deemed necessary or appropriate to conduct its due
diligence investigation. The Purchaser understands that its investment in the
Securities involves a high degree of risk. 

(e)     Rule 144. The Purchaser
understands that the Securities must be held indefinitely unless they are
registered under the Securities Act or an exemption from registration is
available. The Purchaser acknowledges that it is familiar with Rule 144 of the
rules and regulations of the Commission, as amended, promulgated pursuant to the
Securities Act (“Rule 144”), and that the Purchaser has been advised that
Rule 144 permits resales only under certain circumstances. The Purchaser
understands that to the extent that Rule 144 is not available, the Purchaser
will be unable to sell the Securities without either registration under the
Securities Act or the existence of another exemption from such registration
requirement. 

(f)     General. The Purchaser
understands that the Securities are being offered and sold in reliance on a
transactional exemption from the registration requirements of federal and state
securities laws and the Company is relying upon the truth and accuracy of the
representations, warranties, agreements, acknowledgments and understandings of
the Purchaser set forth herein in order to determine the applicability of such
exemptions and the suitability of the Purchaser to acquire the Securities. The
Purchaser understands that no United States federal or state agency or any
government or governmental agency has passed upon or made any recommendation or
endorsement of the Securities. 

(g)     No General Solicitation. The
Purchaser acknowledges that the Securities were not offered to the Purchaser by
means of any form of general or public solicitation or general advertising, or
publicly disseminated advertisements or sales literature, including (i) any
advertisement, article, notice or other communication published in any
newspaper, magazine, Internet website or similar media, or broadcast over
television or radio, or (ii) any seminar or meeting to which the Purchaser was
invited by any of the foregoing means of communications. The Purchaser, in
making the decision to purchase the Securities, has relied upon independent
investigation made by it and its advisors. 

(h)      Accredited Investor.
The Purchaser is an “accredited investor” (as defined in Rule 501 of Regulation
D), and the Purchaser has such experience in business and financial matters that it is capable of evaluating the merits and risks of an
investment in the Securities. The Purchaser is not required to be registered as
a broker-dealer under Section 15 of the Exchange Act and the Purchaser is not a
broker-dealer. The Purchaser has completed the Accredited Investor Status
Certificate attached here to as Appendix I. The Purchaser acknowledges
that an investment in the Securities is speculative and involves a high degree
of risk. 

4 

(i)     Certain Fees. The Purchaser
has not employed any broker or finder or incurred any liability for any
brokerage or investment banking fees, commissions, finders’ structuring fees,
financial advisory fees or other similar fees in connection with the Transaction
Documents. 

(j)     Due Diligence. The Purchaser
hereby represents that, in connection with the Purchaser’s investment or the
Purchaser’s decision to purchase the Notes, the Purchaser has not relied on any
statement or representation of any Person, including any such statement or
representation by the Company or any of its controlling Persons, officers,
directors, partners, agents and employees or any of its respective attorneys,
except as specifically set forth herein. 

ARTICLE III 
CONDITIONS 

Section 3.1     Conditions Precedent to
the Obligation of the Company to Close and to Sell the Notes and
Warrants. The obligation hereunder of the Company to close and issue and
sell the Securities to the Purchaser at each Closing is subject to the
satisfaction or waiver, at or before each Closing of the conditions set forth
below; provided that the condition set forth in (d) below must be satisfied at
or before the initial Closing only. These conditions are for the Company’s sole
benefit and may be waived by the Company at any time in its sole discretion.

(a)     Accuracy of the Purchaser’s
Representations and Warranties. The representations and warranties of the
Purchaser shall be true and correct in all material respects (except for those
representations and warranties that are qualified by materiality which shall be
true and correct in all respects) as of the date when made and as of each
Closing Date as though made at that time, except for representations and
warranties that are expressly made as of a particular date, which shall be true
and correct in all material respects (except for those representations and
warranties that are qualified by materiality, which shall be true and correct in
all respects) as of such date. 

(b)     Performance by the
Purchaser. The Purchaser shall have performed, satisfied and complied in all
material respects with all covenants, agreements and conditions required by this
Agreement to be performed, satisfied or complied with by the Purchaser at or
prior to each Closing Date. 

(c)     Delivery of Purchase Price.
The Company shall have received from the Purchaser the applicable Advance
Amount. 

(d)     Delivery of Transaction
Documents. The Transaction Documents shall have been duly executed and
delivered by the Purchaser to the Company. 

Section 3.2     Conditions Precedent to
the Obligation of the Purchaser to Close and to Purchase the Notes.
The obligation hereunder of the Purchaser to purchase the Securities and
consummate the transactions contemplated by this Agreement is subject to the
satisfaction or waiver, at or before each Closing, of each of the conditions set
forth below. These conditions are for the Purchaser’s sole benefit and may be
waived by the Purchaser at any time in its sole discretion. 

(a)     Accuracy of the Company’s
Representations and Warranties. Each of the representations and warranties
of the Company in this Agreement and the other Transaction Documents shall be
true and correct in all material respects (except for those representations and
warranties that are qualified by materiality or material adverse effect, which
shall be true and correct in all respects) as of the date when made and as of
each Closing Date as though made at that time, except for representations and
warranties that are expressly made as of a particular date, which shall be true
and correct in all material respects (except for those representations and
warranties that are qualified by materiality or material adverse effect, which
shall be true and correct in all respects) as of such date. 

5 

(b)     Performance by the Company.
The Company shall have performed, satisfied and complied in all material
respects with all covenants, agreements and conditions required by this
Agreement to be performed, satisfied or complied with by the Company at or prior
to each Closing Date. 

ARTICLE IV 
MISCELLANEOUS 

Section 4.1     Fees and Expenses.
The Company shall bear its own expenses and legal fees incurred on its behalf
with respect to the negotiation, execution and consummation of the transactions
contemplated by this Agreement. The Company shall pay all reasonable fees and
expenses incurred by the Purchaser in connection with the enforcement of this
Agreement or any of the other Transaction Documents, including, without
limitation, all reasonable attorneys’ fees and expenses. 

Section 4.2     Consent to Jurisdiction;
Venue. The parties agree that venue for any dispute arising under this
Agreement will lie exclusively in the state or federal courts located in New
York County, New York, and the parties irrevocably waive any right to raise
forum non conveniens or any other argument that New York is not the
proper venue. The parties irrevocably consent to personal jurisdiction in the
state and federal courts of the state of New York. The Company and the Purchaser
consent to process being served in any such suit, action or proceeding by
mailing a copy thereof to such party at the address in effect for notices to it
under this Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing in this Section 5.2
shall affect or limit any right to serve process in any other manner permitted
by law. The Company agrees to pay all costs and expenses of enforcement of the
Transaction Documents, including, without limitation, reasonable attorneys’ fees
and expenses. The parties hereby waive all rights to a trial by jury. 

Section 4.3     Entire Agreement;
Amendment. This Agreement and the Transaction Documents contain the entire
understanding and agreement of the parties with respect to the matters covered
hereby and, except as specifically set forth herein or in the other Transaction
Documents, neither the Company nor the Purchaser make any representation,
warranty, covenant or undertaking with respect to such matters, and they
supersede all prior understandings and agreements with respect to said subject
matter, all of which are merged herein. No provision of this Agreement may be
waived or amended other than by a written instrument signed by the Company and
the Purchaser. Any amendment or waiver effected in accordance with this Section
4.3 shall be binding upon the Purchaser (and their permitted assigns) and the
Company. 

Section 4.4     Notices. Any notice,
demand, request, waiver or other communication required or permitted to be given
hereunder shall be in writing and shall be effective (a) upon hand delivery by
telecopy or facsimile at the address or number designated below (if delivered on
a business day during normal business hours where such notice is to be
received), or the first business day following such delivery (if delivered other
than on a business day during normal business hours where such notice is to be
received) or (b) on the third business day following the date of mailing by
express courier service, fully prepaid, addressed to such address, or upon
actual receipt of such mailing, whichever shall first occur. The addresses for
such communications shall be: 

	If to the Company: 	Orgenesis Inc. 
	  	21 Sparrow Circle 
	  	White Plains, Ny 10605 
	  	Attention: Chief Executive Officer 
	  	Tel. No.: (480) 659-6404 
	  	Fax No.: __________
	  	  
	with copies (which copies shall not 	Pearl Cohen Zedek Latzer Baratz 
	constitute notice to the Company) to: 	1500 Broadway 
	  	New York, NY 10036 
	  	Attention: Mark Cohen 
	  	Tel No. (646) 878-0800 
	  	Fax No.: +972-9-764-4834 

6 

	If to the Purchaser: 	_______________________________
	 	 
	with a copy to: 	_________________________

Any party hereto may from time to time change its address for
notices by giving written notice of such changed address to the other party
hereto pursuant to the provisions of this Section 7.4. 

Section 4.5     Waivers. No waiver
by either party of any default with respect to any provision, condition or
requirement of this Agreement shall be deemed to be a continuing waiver in the
future or a waiver of any other provision, condition or requirement hereof, nor
shall any delay or omission of any party to exercise any right hereunder in any
manner impair the exercise of any such right accruing to it thereafter. 

Section 4.6     Headings. The
article, section and subsection headings in this Agreement are for convenience
only and shall not constitute a part of this Agreement for any other purpose and
shall not be deemed to limit or affect any of the provisions hereof. 

Section 4.7     Successors and
Assigns. This Agreement shall be binding upon and inure to the benefit of
the parties and their successors and assigns. After each Closing, the assignment
by a party to this Agreement of any rights hereunder shall not affect the
obligations of such party under this Agreement.

Section 4.8     No Third Party
Beneficiaries. This Agreement is intended for the benefit of the parties
hereto and their respective permitted successors and assigns and is not for the
benefit of, nor may any provision hereof be enforced by, any other person. 

Section 4.9     Governing Law. This
Agreement shall be governed by and construed in accordance with the internal
laws of the State of New York, without giving effect to any of the conflicts of
law principles which would result in the application of the substantive law of
another jurisdiction. This Agreement shall not be interpreted or construed with
any presumption against the party causing this Agreement to be drafted. 

Section 4.10     Survival. The
representations and warranties of the Company and the Purchaser shall survive
the execution and delivery hereof and the Closing hereunder. 

Section 4.11     Counterparts. This
Agreement may be executed in any number of counterparts (including those
delivered by facsimile or other electronic means), all of which taken together
shall constitute one and the same instrument and shall become effective when
counterparts have been signed by each party and delivered to the other parties
hereto, it being understood that all parties need not sign the same counterpart.

Section 4.12     Severability. The
provisions of this Agreement are severable and, in the event that any court of
competent jurisdiction shall determine that any one or more of the provisions or
part of the provisions contained in this Agreement shall, for any reason, be
held to be invalid, illegal or unenforceable in any respect, such invalidity,
illegality or unenforceability shall not affect any other provision or part of a
provision of this Agreement and this Agreement shall be reformed and construed
as if such invalid or illegal or unenforceable provision, or part of such
provision, had never been contained herein, so that such provisions would be
valid, legal and enforceable to the maximum extent possible. 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

7 

IN WITNESS WHEREOF, the parties hereto have caused this Note
Purchase Agreement to be duly executed by their respective authorized officers
as of the date first above written. 

	 	ORGENESIS INC. 
	 	  
	 	By: 	/s/ Vered Caplan 
	 		Name: Vered Caplan 
	 		Title: Chief Executive Officer 
	 	  
	 	  
	 	PURCHASER: 
	 	 
	 	 	

8 

Appendix I 
to the
Securities Purchase Agreement
dated as of October 30, 2015 

ACCREDITED INVESTOR CERTIFICATION 

Capitalized terms not specifically defined in this certificate
shall have the meanings ascribed to such terms in the Securities Purchase
Agreement to which this Certificate is attached.

The Purchaser hereby represents, warrants and certifies to the
Company, as an integral part of the Securities Purchase Agreement, that he, she
or it is and at the Closing Date will be correctly and accurately described in
all respects described by the category or categories set forth directly next to
which the Purchaser has marked below: 

[  ]
(1)           a natural person
whose individual net worth, or joint net with that person’s spouse, at the date
of this certificate exceeds $1,000,000, exclusive of the value of the primary
residence of such person(s) and the related amount of indebtedness secured by
the primary residence up to its fair market value; 

[  ]
(2)           a natural person
who had an individual net income in excess of $200,000 in each of the two most
recent fiscal years or joint income with that person’s spouse in excess of
$300,000 in each of those years and has a reasonable expectation of reaching the
same income level in the current year;

[  ] (3)        
  an organization described in Section 501(c ) (3) of the Internal Revenue
Code, a corporation, a Massachusetts or similar business trust or partnership,
not formed for the specific purpose of acquiring the Securities, with total
assets in excess of $5,000,000;

[  ] 4       
  a director or executive officer of the Company;

[  ] 5      
  a trust with total assets in excess of $5,000,000, not formed for the
specific purpose of acquiring the Securities, whose purchase is directed by a
sophisticated person as described in Rule 506(b)(2)(ii) under the Securities Act
of 1933, as amended;

[  ] 6          an
entity in which all of the equity owners satisfy the requirements of one or more
of the foregoing categories. 

Dated: __________________

_____________________________
[PURCHASER] 

9 

EXHIBIT A 
TO 
SECURITIES PURCHASE AGREEMENT

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT
OF 1933, AS AMENDED (THE “ACT”), OR APPLICABLE STATE SECURITIES LAWS, AND MAY
NOT BE SOLD, TRANSFERRED, OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH
REGISTRATION OR RECEIPT BY THE MAKER OF AN OPINION OF COUNSEL IN THE FORM,
SUBSTANCE AND SCOPE REASONABLY SATISFACTORY TO THE MAKER THAT THIS NOTE MAY BE
SOLD, TRANSFERRED, OR OTHERWISE DISPOSED OF, UNDER AN EXEMPTION FROM
REGISTRATION UNDER THE ACT AND SUCH STATE SECURITIES LAWS. 

ORGENESIS INC. 

Promissory Note 
due November 30, 2016 

	No. ____	$_______________ 
	 	 
	Dated: __________	  

For value received, Orgenesis Inc., a Nevada corporation (the
“Maker” or the “Company”), hereby promises to pay to the order of
_____________(together with its successors, representatives, and permitted
assigns, the “Holder”), in accordance with the terms hereinafter
provided, the principal amount of ____________($_________), together with
interest thereon. 

All payments under or pursuant to this Note shall be made,
without setoff or counterclaim and without any withholding or deduction
whatsoever, in United States Dollars in immediately available funds to the
Holder at the address of the Holder first set forth above or at such other place
as the Holder may designate from time to time in writing to the Maker or by wire
transfer of funds to the Holder’s account, instructions for which are attached
hereto as Exhibit A. The outstanding principal balance of this Note shall
be due and payable on November 30, 2016 (the “Maturity Date”) or at such
earlier time as provided herein. This Note may be prepaid in whole or part
without premium or penalty.

ARTICLE I 

Section 1.1     Purchase Agreement.
This Note has been executed and delivered pursuant to the Securities Purchase
Agreement dated as of October 30, 2015 (the “Purchase Agreement”) by and
between the Maker and Holder. Capitalized terms used and not otherwise defined
herein shall have the meanings set forth for such terms in the Purchase
Agreement. 

Section 1.2     Interest. Beginning
on the issuance date of this Note (the “Issuance Date”), the outstanding
principal balance of this Note shall bear interest, in arrears, at a rate per
annum equal to twelve percent (12%), payable quarterly commencing on the first
business day following the first fiscal quarter-end following issuance and on
the first business day of each following three-month period in cash. Interest
shall be computed on the basis of a 360-day year of twelve (12) 30-day months
and shall accrue commencing on the Issuance Date. Furthermore, upon the
occurrence of an Event of Default (as defined in Section 2.1 hereof), then to
the extent permitted by law, the Maker will pay interest to the Holder, payable
on demand, on the outstanding principal balance of the Note from the date of the
Event of Default until such Event of Default is cured at the rate of the lesser
of twenty five percent (25%) and the maximum applicable legal rate per annum.

Section 1.3      Payment on
Non-Business Days. Whenever any payment to be made shall be due on a
Saturday, Sunday or a public holiday under the laws of the State of New York,
such payment may be due on the next succeeding business day and such next
succeeding day shall be included in the calculation of the amount of accrued
interest payable on such date. 

1 

Section 1.4     Transfer. This Note
may be transferred or sold, subject to the provisions of Section 4.8 of this
Note, or pledged, hypothecated or otherwise granted as security by the Holder
without the written consent of the Company.

Section 1.5     Replacement. Upon
receipt of a duly executed, notarized and unsecured written statement from the
Holder with respect to the loss, theft or destruction of this Note (or any
replacement hereof) and a standard indemnity, or, in the case of a mutilation of
this Note, upon surrender and cancellation of such Note, the Maker shall issue a
new Note, of like tenor and amount, in lieu of such lost, stolen, destroyed or
mutilated Note. 

ARTICLE II 
EVENTS OF DEFAULT; REMEDIES

Section 2.1     Events of Default.

(a)     The occurrence of any of the
following events shall be an “Event of Default” under this Note: 

(i)     the Maker shall fail to make any
principal or interest payments on the date such payments are due, whether at
maturity or at a date fixed for prepayment or by acceleration or otherwise, and
such default is not fully cured within two (2) business days after the Holder
delivers written notice to the Maker of the occurrence thereof; or 

(ii)     any material representation or
warranty made by the Maker herein or in the Purchase Agreement or any other
Transaction Document shall prove to have been false or incorrect or breached in
a material respect on the date as of which made and the Holder delivers written
notice to the Maker of the occurrence thereof; or 

(iii)      the Maker shall (A) apply
for or consent to the appointment of, or the taking of possession by, a
receiver, custodian, trustee or liquidator of itself or of all or a substantial
part of its property or assets, (B) make a general assignment for the benefit of
its creditors, (C) commence a voluntary case under the United States Bankruptcy
Code (as now or hereafter in effect) or under the comparable laws of any
jurisdiction (foreign or domestic), (D) file a petition seeking to take
advantage of any bankruptcy, insolvency, moratorium, reorganization or other
similar law affecting the enforcement of creditors’ rights generally, (E)
acquiesce in writing to any petition filed against it in an involuntary case
under United States Bankruptcy Code (as now or hereafter in effect) or under the
comparable laws of any jurisdiction (foreign or domestic), or admit in writing
its inability to pay its debts (F) issue a notice of bankruptcy or winding down
of its operations or issue a press release regarding same, or (G) take any
action under the laws of any jurisdiction (foreign or domestic) analogous to any
of the foregoing; or 

(iv)     a proceeding or case shall be
commenced in respect of the Maker, without its application or consent, in any
court of competent jurisdiction, seeking (A) the liquidation, reorganization,
moratorium, dissolution, winding up, or composition or readjustment of its
debts, (B) the appointment of a trustee, receiver, custodian, liquidator or the
like of it or of all or any substantial part of its assets in connection with
the liquidation or dissolution of the Maker or (C) similar relief in respect of
it under any law providing for the relief of debtors, and such proceeding or
case described in clause (A), (B) or (C) shall continue undismissed, or unstayed
and in effect, for a period of sixty (60) days or any order for relief shall be
entered in an involuntary case under United States Bankruptcy Code (as now or
hereafter in effect) or under the comparable laws of any jurisdiction (foreign
or domestic) against the Maker or action under the laws of any jurisdiction
(foreign or domestic) analogous to any of the foregoing shall be taken with
respect to the Maker and shall continue undismissed, or unstayed and in effect
for a period of thirty (30) days. 

Section 2.2     Remedies Upon An Event
of Default. If an Event of Default shall have occurred and shall be
continuing, the Holder of this Note may at any time at its option, (a) declare
the entire unpaid principal balance of this Note, together with all interest
accrued hereon, due and payable, and thereupon, the same shall be accelerated
and so due and payable, without presentment, demand, protest, or notice, all of
which are hereby expressly unconditionally and irrevocably waived by the Maker;
provided, however, that upon the occurrence of an Event of Default
described in (i) Sections 2.1 (a)(iii) or (iv), the outstanding principal balance and accrued interest
hereunder shall be automatically due and payable and (ii) Sections 2.1
(a)(i)-(ii), Holder may demand the prepayment of this Note pursuant to Section
3.1 hereof, or (b) exercise or otherwise enforce any one or more of the Holder’s
rights, powers, privileges, remedies and interests under this Note, the Purchase
Agreement, or applicable law. In case of a default in the payment of any
principal of or interest on a Note, the Maker will pay to the Holder such
further amount as shall be sufficient to cover the cost and the expenses of
collection, including, without limitation, reasonable attorney’s fees, expenses
and disbursements. No course of delay on the part of the Holder shall operate as
a waiver thereof or otherwise prejudice the right of the Holder. No remedy
conferred hereby shall be exclusive of any other remedy referred to herein or
now or hereafter available at law, in equity, by statute or otherwise. 

2 

ARTICLE III 
PREPAYMENT 

Section 3.1     Prepayment. 

(a)     Prepayment Upon an Event of
Default. Notwithstanding anything to the contrary contained herein, upon the
occurrence of an Event of Default described in Sections 2.1(a)(i) through a(ii)
hereof, the Holder shall have the right, at such Holder’s option, to require the
Maker to prepay in cash all or a portion of this Note at a price equal to one
hundred percent (100%) of the aggregate principal amount of this Note being
prepaid plus all accrued and unpaid interest applicable at the time of such
request. Nothing in this Section 3.1(a) shall limit the Holder’s rights under
Section 2.2 hereof. 

(b)     Prepayment Upon Major
Transaction. In addition to all other rights of the Holder contained herein,
simultaneous with the occurrence of a Major Transaction (as defined below), the
Maker shall prepay in cash all of the Holder’s Notes at a price equal to one
hundred percent (100%) of the aggregate principal amount of this Note being
prepaid plus all accrued and unpaid interest (the “Major Transaction
Prepayment Price”). 

(c)     Major Transaction. A
“Major Transaction” shall be deemed to have occurred at such time as any
of the following events: 

(i)     the merger or consolidation of the
Company or any subsidiary of the Company in one or a series of related
transactions with or into another entity (except in connection with a merger
involving the Company solely for the purpose, and with the sole effect, of
reorganizing the Company under the laws of another jurisdiction; provided that
the certificate of incorporation and bylaws (or similar charter or
organizational documents) of the surviving entity are substantively identical to
those of the Company and do not otherwise adversely impair the rights of the
Purchaser) where the Company is not the surviving entity; 

(ii)     the sale, transfer, lease, or
other disposition of 50% or more of the consolidated assets of the Maker (as
shown on the most recent financial statements of the Maker) in any single
transaction or series of related transactions (other than the sale of inventory
in the ordinary course of business), or the liquidation, dissolution,
recapitalization or reorganization in any form of transaction, or acquisition of
all or substantially all of the capital stock or assets of another business or
entity to the extent not otherwise permitted by the Purchase Agreement; or 

(iii)     the equity investment by any
third party in the Maker pursuant to a transaction in which the Maker places
shares of its common stock or securities convertible into common stock in
consideration of gross proceeds paid into the Company of at least $10 million;
provided that in the event of such investment the Holder shall be
entitled to prepayment under Section 3.1(b) only to the extent to which the
gross proceeds of such investment exceed $10 million; provided
further that any such prepayment shall be allocated pro rata among
all Notes then outstanding. 

(d)      Mechanics of Prepayment at
Option of Holder Upon Major Transaction. No sooner than fifteen (15) days
nor later than ten (10) days prior to the consummation of a Major Transaction,
but not prior to the public announcement of such Major Transaction, the Maker
shall deliver written notice thereof via facsimile and overnight courier
(“Notice of Major Transaction”) to the Holder of this Note. At any time after receipt of a Notice
of Major Transaction (or, in the event a Notice of Major Transaction is not
delivered at least ten (10) days prior to a Major Transaction, at any time
within ten (10) days prior to a Major Transaction), the Holder of this Note may
require the Maker to prepay, effective concurrently with the consummation of
such Major Transaction, all or any portion of this Note then outstanding by
delivering written notice thereof via facsimile and overnight courier
(“Notice of Prepayment at Option of Holder Upon Major Transaction”) to
the Maker, which Notice of Prepayment at Option of Holder Upon Major Transaction
shall indicate (i) the principal amount of this Note that the Holder is electing
to have prepaid and (ii) the applicable Major Transaction Prepayment Price, as
calculated pursuant to Section 3.1(b) above. 

3 

(i)     Payment of Prepayment Price.
Upon the Maker’s receipt of a Notice(s) of Prepayment at Option of Holder Upon
Major Transaction from the Holder, the Maker shall immediately notify the Holder
by facsimile of the Maker’s receipt of such Notice(s) of Prepayment at Option of
Holder Upon Major Transaction and the Holder which has sent such a notice shall
promptly submit to the Maker the Holder’s certificates representing this Note
which the Holder has elected to have prepaid. The Maker shall deliver the
applicable Major Transaction Prepayment Price immediately prior to the
consummation of the Major Transaction; provided that the Holder’s original Note
shall have been so delivered to the Maker. If the Maker shall fail to prepay all
of the Notes submitted for prepayment (other than pursuant to a dispute as to
the arithmetic calculation of the Prepayment Price), in addition to any remedy
such holder of the Notes may have under this Note and the Purchase Agreement,
the applicable Prepayment Price payable in respect of such Notes not prepaid
shall bear interest at the rate of two percent (2%) per month (prorated for
partial months) or the maximum rate permitted by law, if less, until paid in
full. Until the Maker pays such unpaid applicable Prepayment Price in full to a
holder of the Notes submitted for prepayment, such holder shall have the option
(the “Void Optional Prepayment Option”) to, in lieu of prepayment,
require the Maker to promptly return to such holder(s) all of the Notes that
were submitted for prepayment by such holder(s) under this Section 3.1 and for
which the applicable Prepayment Price has not been paid, by sending written
notice thereof to the Maker via facsimile (the “Void Optional Prepayment
Notice”). Upon the Maker’s receipt of such Void Optional Prepayment
Notice(s) and prior to payment of the full applicable Prepayment Price to such
holder, (i) the Notice(s) of Prepayment at Option of Holder Upon Major
Transaction shall be null and void with respect to those Notes submitted for
prepayment and for which the applicable Prepayment Price has not been paid, (ii)
the Maker shall immediately return any Notes submitted to the Maker by each
holder for prepayment under this Section 3.1(j) and for which the applicable
Prepayment Price has not been paid. A holder’s delivery of a Void Optional
Prepayment Notice and exercise of its rights following such notice shall not
affect the Maker’s obligations to make any payments which have accrued prior to
the date of such notice. Payments provided for in this Section 3.1 shall have
priority to payments to stockholders in connection with a Major Transaction.

Section 3.2     No Rights as
Shareholder. Nothing contained in this Note shall be construed as conferring
upon the Holder the right to vote or to receive dividends or to consent or to
receive notice as a shareholder in respect of any meeting of shareholders for
the election of directors of the Maker or of any other matter, or any other
rights as a shareholder of the Maker. 

ARTICLE IV 
MISCELLANEOUS 

Section 4.1     Notices. Any notice,
demand, request, waiver or other communication required or permitted to be given
hereunder shall be in writing and shall be effective (a) upon hand delivery,
telecopy or facsimile at the address or number designated in the Purchase
Agreement (if delivered on a business day during normal business hours where
such notice is to be received), or the first business day following such
delivery (if delivered other than on a business day during normal business hours
where such notice is to be received) or (b) on the second business day following
the date of mailing by express courier service, fully prepaid, addressed to such
address, or upon actual receipt of such mailing, whichever shall first occur.

Section 4.2     Governing Law. This
Note shall be governed by and construed in accordance with the internal laws of
the State of New York, without giving effect to any of the conflicts of law
principles which would result in the application of the substantive law of
another jurisdiction. This Note shall not be interpreted or construed with any
presumption against the party causing this Note to be drafted. 

4 

Section 4.3      Headings.
Article and section headings in this Note are included herein for purposes of
convenience of reference only and shall not constitute a part of this Note for
any other purpose. 

Section 4.4      Remedies,
Characterizations, Other Obligations, Breaches and Injunctive Relief. The
remedies provided in this Note shall be cumulative and in addition to all other
remedies available under this Note, the Transaction Documents, at law or in
equity (including, without limitation, a decree of specific performance and/or
other injunctive relief), no remedy contained herein shall be deemed a waiver of
compliance with the provisions giving rise to such remedy and nothing herein
shall limit a Holder’s right to pursue actual damages for any failure by the
Maker to comply with the terms of this Note. Amounts set forth or provided for
herein with respect to payments and the like (and the computation thereof) shall
be the amounts to be received by the Holder thereof and shall not, except as
expressly provided herein, be subject to any other obligation of the Maker (or
the performance thereof). The Maker acknowledges that a breach by it of its
obligations hereunder will cause irreparable and material harm to the Holder and
that the remedy at law for any such breach may be inadequate. Therefore the
Maker agrees that, in the event of any such breach or threatened breach, the
Holder shall be entitled, in addition to all other available rights and
remedies, at law or in equity, to seek and obtain such equitable relief,
including but not limited to an injunction restraining any such breach or
threatened breach, without the necessity of showing economic loss and without
any bond or other security being required. 

Section 4.5     Enforcement
Expenses. The Maker agrees to pay all costs and expenses of enforcement of
this Note, including, without limitation, reasonable attorneys’ fees and
expenses. 

Section 4.6     Binding Effect. The
obligations of the Maker and the Holder set forth herein shall be binding upon
the successors and assigns of each such party, whether or not such successors or
assigns are permitted by the terms hereof. 

Section 4.7     Amendments. This
Note may not be modified or amended in any manner except in writing executed by
the Maker and the Holder. 

Section 4.8     Compliance with
Securities Laws. The Holder of this Note acknowledges that this Note is
being acquired solely for the Holder’s own account and not as a nominee for any
other party, and for investment, and that the Holder shall not offer, sell or
otherwise dispose of this Note. This Note and any Note issued in substitution or
replacement therefor shall be stamped or imprinted with a legend in
substantially the following form: 

“THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933, AS AMENDED (THE “ACT”), OR APPLICABLE STATE SECURITIES LAWS, AND MAY NOT
BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR RECEIPT BY THE
MAKER OF AN OPINION OF COUNSEL IN THE FORM, SUBSTANCE AND SCOPE REASONABLY
SATISFACTORY TO THE MAKER THAT THIS NOTE MAY BE SOLD, TRANSFERRED, HYPOTHECATED
OR OTHERWISE DISPOSED OF, UNDER AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND
SUCH STATE SECURITIES LAWS.” 

Section 4.9     Specific Performance;
Consent to Jurisdiction; Venue. 

(a)     The Maker and the Holder
acknowledge and agree that irreparable damage would occur in the event that any
of the provisions of this Note or the other Transaction Documents were not
performed in accordance with their specific terms or were otherwise breached. It
is accordingly agreed that the parties shall be entitled to an injunction or
injunctions to prevent or cure breaches of the provisions of this Agreement or
the other Transaction Documents and to enforce specifically the terms and
provisions hereof or thereof, this being in addition to any other remedy to
which any of them may be entitled by law or equity. 

(b)     The parties agree that venue for
any dispute arising under this Note will lie exclusively in the state or federal
courts located in New York County, New York, and the parties irrevocably waive
any right to raise forum non conveniens or any other argument that New
York is not the proper venue. The parties irrevocably consent to personal
jurisdiction in the state and federal courts of the state of New York. The Maker
and Holder consent to process being served in any such suit, action or
proceeding by mailing a copy thereof to such party at the address in effect for
notices to it under the Purchase Agreement and agrees that such service shall
constitute good and sufficient service of process and notice thereof. Nothing in
this Section 4.9 shall affect or limit any right to serve process in any other
manner permitted by law. The parties hereby waive all rights to a trial by jury.

5 

Section 4.10     Parties in
Interest. This Note shall be binding upon, inure to the benefit of and be
enforceable by the Maker, the Holder and their respective successors and
permitted assigns. 

Section 4.11      Failure or
Indulgence Not Waiver. No failure or delay on the part of the Holder in the
exercise of any power, right or privilege hereunder shall operate as a waiver
thereof, nor shall any single or partial exercise of any such power, right or
privilege preclude other or further exercise thereof or of any other right,
power or privilege. No delay or omission on the part of the Holder in exercising
its rights under this Note, or course of conduct relating hereto, shall operate
as a waiver of such rights or any other right of the Holder, nor shall any
waiver by the Holder of any such right or rights on any one occasion be deemed a
waiver of the same right or rights on any future occasion 

Section 4.12     Maker
Waivers. Except as otherwise specifically provided herein, the Maker and all
others that may become liable for all or any part of the obligations evidenced
by this Note, hereby waive presentment, demand, notice of nonpayment, protest
and all other demands and notices in connection with the delivery, acceptance,
performance and enforcement of this Note, and do hereby consent to any number of
renewals of extensions of the time or payment hereof and agree that any such
renewals or extensions may be made without notice to any such persons and
without affecting their liability herein and do further consent to the release
of any person liable hereon, all without affecting the liability of the other
persons, firms or Maker liable for the payment of this Note, AND THE PARTIES
HERETO DO HEREBY WAIVE TRIAL BY JURY. 

(a)     THE MAKER ACKNOWLEDGES THAT THE
TRANSACTION OF WHICH THIS NOTE IS A PART IS A COMMERCIAL TRANSACTION, AND TO THE
EXTENT ALLOWED BY APPLICABLE LAW, HEREBY WAIVES ITS RIGHT TO NOTICE AND HEARING
WITH RESPECT TO ANY PREJUDGMENT REMEDY WHICH THE HOLDER OR ITS SUCCESSORS OR
ASSIGNS MAY DESIRE TO USE. 

Section 4.13     Transfer and Assignment. The Holder may
transfer or assign this Note without the consent of the Maker. The Maker may not
transfer or assign this Note or its obligations hereunder without the consent of
the Holder 

6 

IN WITNESS WHEREOF, the Maker has caused this Note to be signed
on the day and year first above written. 

	 	ORGENESIS INC. 
	 	  
	 	By: 	 
	 		Name: 
	 		Title: 

7Exhibit 10.11 Consulting Agreement

Confidential

May 1, 2015

Tim Treu

931 West Northridge Road Farmington, Utah 84025

Subject: CONSULTING AGREEMENT LETTER

This agreement ("Agreement") dated 30 April 2015 is made by and between Fresh Medical Laboratories, Inc. ("FML," the "Company" or "ProLung") a Delaware Corporation whose principal address is 757 East South Temple, Suite 150, Salt Lake City, UT 84102 ("Company"), AND Tim Treu located at 931 West Northridge Road, Farmington, Utah 84025 ("Consultant.").

1.

Consultation Services: The Company hereby employs the Consultant to perform the marketing services in accordance with the terms and conditions set forth in this Agreement. Marketing advisory services include functioning as the Chief Marketing and Sales Officer of the Company. No other agreement written or verbal is recognized, precludes, amends or predates this Agreement between Consultant and FML. The Consultant will assist in the clinical direction and regulatory approvals of the Company and others mutually agreed assignments from time to time. In that capacity, the Consultant will report to the Chief Executive Officer.

2.

Conflict of Interest: The Consultant will promptly disclose to and notify the management of the Company of any potential conflict of interest in the performance of his duties as a consultant. The Consultant maintains and supports the business interests of FML and shall not informally or officially represent any potential Partner or Partners without the prior written approval of FML.

3.

Payment to Consultant: On projects approved in advance by the Company, the Consultant will be paid a cash retainer of $1,000 per week ("Compensation") by FML for 8 hours of time. Cash payments will occur each Friday.

4.

Interest: The Consultant will be required to represent and promote uniquely and fully the interests of the Company and its Management and Affiliates at all times and refrain from receiving or agreeing to receive Incentive Compensation by any other party, group of individual introduced by you to the Company. The Consultant also agrees to refrain from withholding information that is critical to the Company which has been disclosed by any party introduced to the Company by the Consultant.

Page 2

May 1, 2015

5.

Complete Agreement: The Consultant and the Company, agree that this Offer constitutes the only offer between the Consultant and the Company and no other conditions are agreed other than those set forth herein. Further, the Parties agree that this Offer remain in effect for the Term of the Offer unless terminated by either Party in writing.

6.

Termination: Either the Consultant or the Company may terminate this agreement at any time and for any purpose.

7.

Breach: If there is a breach in the Confidentiality or Interest provision of this Offer, as determined by the Company, and, having advised the Consultant remains uncured for 30 days, this Offer is rescinded and any Incentive Compensation granted hereby cancelled.

8.

Expenses: The Consultant will be reimbursed for reasonable business expenses. The Consultant may be asked to produce receipts, and it is easier for the Company if the Consultant gets a quick prior approval for any major expense prior to the Consultants commitment in order for the Company to reimburse in a timely way.

9.

Contractor: Under the law of the State of Utah, the Consultant is an area Contractor. As such the Consultant is responsible for their own taxes and are not able to obligate the Company, or represent the Company on their own.

10.

Confidential Information: During the Tern of this agreement, the Consultant agrees to be bound by the Confidentiality and on Disclosure Agreement ("CDA").

The Company and the Consultant to do hereby agree with the foregoing this day April 20, 2015:

/s/ Steven C. Eror                            

Fresh Medical Laboratories, Inc.

By Steven C. Eror

Its President and CEO

/s/ Tim Treu                                      

By Tim Treu

Chief Marketing & Sales Officer Consultant

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00256-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00256-of-00352.parquet"}]]